T 1294/21 (Targeted modification of a genome/REGENERON PHARMACEUTICALS) of 03.08.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T129421.20230803
- Date of decision
- 3 August 2023
- Case number
- T 1294/21
- Petition for review of
- -
- Application number
- 14790457.7
- IPC class
- C12N 15/85C12N 9/22
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME
- Applicant name
- Regeneron Pharmaceuticals, Inc.
- Opponent name
- CMS Cameron McKenna Nabarro Olswang LLP
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(1)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Cited cases
- T 0073/84
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.